The Pharmacy Times® Flu resource center provides information about early symptoms of the flu and the array of therapies in development intended to treat it as it progresses. Additionally, learn more about the data coming directly from the most widely attended pharmacy conferences and meetings, updated clinical trial listings, and other resources.
Investigational COVID-19 antibody was authorized in a 700 mg dose for adults and pediatric patients 12 years and older and should be administered as soon as possible after diagnosis and within 10 days of symptom onset.
A new study suggests that COVID-19 antibodies remain in the body for up to 5 months.
The Pharmacy Times® Flu specialty page serves as a hub for all clinical news and articles related to the contagious respiratory condition. Additionally, the flu specialty page provides multiple condition-specific resources, ranging from atherosclerosis and chronic angina to heart failure and stroke prevention.